T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Revvity, Inc. (NYSE:RVTY) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 22,447,103 shares of the Healthcare company, valued at approximately $2.2B as of the filing date.
Revvity, Inc.'s stock currently trades at $98.08 with a market capitalization of $12.3B.
